Ana Petrovic

Director of Investments, Interim COO

“Strategies take time to shape—optionality and flexibility are important.”

Few things are more rewarding than partnering with pioneers who are inventing new industries and markets. My enthusiasm for leading-edge innovation and entrepreneurship has brought me to Silicon Valley. I am in awe of entrepreneurs who challenge the norm and build—realized and unrealized—transformative technologies, which fill an unmet need, solve undeniable problems, and create value.

At Pilatus Capital I support founders to actualize their vision. The hallmark of my career is adaptability—I have worn many hats. My experience in equity research, investor relations, venture capital, bench research and corporate development equips me with a diverse skill set, which entrepreneurs can leverage to pave their paths and create their dreams.

You build your toolbox over time. I grew up in Washington D.C. and was the kid who geeked out on science fairs and had a passion for discovery. Initially, I studied microbiology and biochemistry and began my career at the National Institutes of Health as a molecular biologist researching HIV. After a couple of years of working in a lab, I wanted to leverage my scientific background and cover healthcare stocks in equity research. This led me to pursue my MBA at the University of Chicago Booth School of Business, and then to go on and work on Wall Street.

Sell-side equity research is a fast-paced, demanding environment. You are always on call. But it was an invaluable experience for me. I covered small-, mid-, and large-cap biopharma companies across a range of therapeutic areas including rare disease, infectious diseases, oncology, and diabetes. I assessed CEOs and their teams on strategy execution in bull markets and through economic downturns such as the Great Recession.

Strategies take time to shape—optionality and flexibility are important. I moved to the corporate side, to gain operations experience, and joined a small-cap public company to work in corporate development and investor relations. I gained insight into the daily operations of the company and had skin in the game around our strategic decisions. As head of investor relations, I played a strategic role in capital raising and communications between the market and our management team.

Venture debt funding provides investor-backed startups with a non-dilutive financing option. I partnered with innovative private and public companies providing them with customizable, flexible financing solutions to extend their cash runway, grow their business and/or strengthen their balance sheet before an IPO or M&A event.

Education

University of Maryland
BS, Microbiology

George Washington University
MS, Biochemistry

University of Chicago, Booth School of Business
MBA, Finance and Marketing

Professional Experience

Hercules Capital
Vice President, Life Science Deal Team

Fluidigm
Director, Corporate Development and Investor Relations

Lazard Capital Markets
Senior Associate, Equity Research Biotechnology Team